共 190 条
[1]
Kocarnik JM(2022)Cancer Incidence, Mortality, Years of Life Lost, Years lived with disability, and disability-adjusted life years for 29 Cancer Groups from 2010 to 2019: a systematic analysis for the global burden of Disease Study 2019 JAMA Oncol 8 420-44
[2]
Compton K(2022)Cancer incidence and mortality in China, 2016 J Natl Cancer Cent 2 1-9
[3]
Dean FE(2008)NCCN Task Force Report: oral chemotherapy J Natl Compr Canc Netw 6 1-14
[4]
Fu W(2016)Value, Access, and cost of Cancer Care Delivery at Academic Cancer Centers J Natl Compr Canc Netw 14 837-47
[5]
Gaw BL(2017)Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home setting J Oncol Pharm Pract 23 350-78
[6]
Harvey JD(2021)Financial toxicity in cancer care: origins, impact, and solutions Transl Behav Med 11 2043-54
[7]
Zheng R(2018)The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment CA Cancer J Clin 68 153-65
[8]
Zhang S(2021)Out-of-pocket and reimbursed expenses of inpatients with major noncommunicable chronic diseases in China, 2013 Chin J Public Health 37 623-6
[9]
Zeng H(2017)Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey Chin J Cancer 36 41-65
[10]
Wang S(2020)Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer 28 4645-92